Acceleron Pharma Inc.
Variant ActRIIB proteins and uses thereof
Last updated:
Abstract:
In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of red blood cells or a tissue, such as bone, cartilage, muscle, fat, and/or neuronal tissue. The present invention also provides methods of screening compounds that modulate activity of an ActRIIB protein and/or an ActRIIB ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRIIB protein and/or an ActRIIB ligand.
Status:
Grant
Type:
Utility
Filling date:
5 Oct 2017
Issue date:
8 Mar 2022